All eyes are on the multibillion-dollar race for a vaccine. AlphaSense sat down with Carter Gould, U.S. Biopharma Analyst, to discuss timelines and doses.
AlphaSense Staff
Last week, Morgan Stanley’s Global Healthcare Conference drew 150 global healthcare giants. Read commentary on the progress of their Covid vaccine trials.
AlphaSense Analyst
Last week, AlphaSense sat down with Ricky Goldwasser, US Healthcare Services Analyst at Morgan Stanley, to discuss telehealth, telemedicine and healthcare.
This week, Moderna announced its first successful test of a coronavirus vaccine, while healthcare giants presented at the UBS Global Healthcare Conference.
The entire value chain of healthcare, from drug development to healthcare delivery, is actively responding to the growing impact of the Coronavirus. Read more here.
Vishesh Kumar
The implications of a possible Sanders Presidency amid his strong momentum is keeping many on Wall Street up at night. Read more about Sanders' potential impact.
Last week, Coronavirus was one of the most asked-about topics on earnings calls. Our team compiled a quick snapshot of Coronavirus in Press Releases, 10Ks & more.
As Coronavirus causes an economic catastrophe, the Chinese online sector and a slew of biotechs have discovered potential investment opportunities from the epidemic.
For those in the healthcare industry, knowledge of regulatory activities and FDA drug approvals can be critical to competitive intelligence.
At the BIO CEO & Investor Conference 2019, AlphaSense discusses the shifting M&A landscape following a record-setting year of biotech IPOs.
{{ post.author.name }} {{ post.author.title }}
{{ post.intro }}